FDA recall D-0355-2026

Teva Pharmaceuticals USA, Inc · Class II · drug

Product

Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054

Reason for recall

Failed Dissolution Specifications

Distribution

Nationwide

Key facts

Status: Ongoing
Initiation date: 2026-01-29
Report date: 2026-03-11
Voluntary/Mandated: Voluntary: Firm initiated
Location: Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0355-2026